Langsenlehner Tanja, Mayer Ramona, Quehenberger Franz, Prettenhofer Ulrike, Langsenlehner Uwe, Pummer Karl, Kapp Karin S
Department of Therapeutic Radiology and Oncology, Medical University of Graz, Graz, Austria.
Strahlenther Onkol. 2008 Jul;184(7):359-63. doi: 10.1007/s00066-008-1818-2. Epub 2008 Oct 1.
To retrospectively assess the outcome in patients treated with adjuvant radiotherapy for penile cancer.
Between 1987 and 2006, 24 patients (median age, 62.7 years; range, 35.5-90.4 years) with squamous cell carcinoma of the penis (T1, n = 10; T2, n = 11; T3, n = 3) received megavoltage external radiotherapy (n = 22) or (192)Ir high-dose-rate brachytherapy (n = 2) following total penectomy (n = 7), partial penectomy (n = 10), or local excision (n = 7); lymphadenectomy was performed in eight patients. In 14 patients, radiotherapy was delivered after incomplete tumor resection, and in 20 patients the planning target volume included the regional lymph nodes. Median total dose of external radiotherapy was 56 Gy/1.8-2 Gy (range, 50-60 Gy). Brachytherapy was given with a total dose of 45 Gy/3 Gy.
During a median follow-up of 58.4 months, penile or perineal recurrence was found in four patients giving a 5-year local control rate of 74.8%. Regional failure occurred in two patients. 5-year metastases-free survival and progression-free survival rates were 86.7% and 64.5%, respectively. Four patients died due to tumor progression. The actuarial 5-year cause-specific and overall survival rates were 84.3 and 56.6%, respectively.
Radiation therapy is a successful method of treatment for penile cancer in terms of local control and organ preservation after microscopically incomplete surgery. Radiotherapy of the regional lymph nodes might also be effective in preventing regional recurrence and can be considered in case of high-risk features and following excision of extensive lymph node involvement.
回顾性评估阴茎癌患者接受辅助放疗的疗效。
1987年至2006年间,24例阴茎鳞状细胞癌患者(中位年龄62.7岁;范围35.5 - 90.4岁),其中T1期10例、T2期11例、T3期3例,在接受全阴茎切除术(7例)、部分阴茎切除术(10例)或局部切除术(7例)后,接受了兆伏级外照射放疗(22例)或铱-192高剂量率近距离放疗(2例);8例患者进行了淋巴结清扫术。14例患者在肿瘤切除不完全后接受放疗,20例患者的计划靶体积包括区域淋巴结。外照射放疗的中位总剂量为56 Gy/1.8 - 2 Gy(范围50 - 60 Gy)。近距离放疗的总剂量为45 Gy/3 Gy。
中位随访58.4个月期间,4例患者出现阴茎或会阴复发,5年局部控制率为74.8%。2例患者出现区域复发。5年无转移生存率和无进展生存率分别为86.7%和64.5%。4例患者因肿瘤进展死亡。5年精算特定病因生存率和总生存率分别为84.3%和56.6%。
就显微镜下手术不完全后的局部控制和器官保留而言,放射治疗是治疗阴茎癌的一种成功方法。区域淋巴结的放射治疗在预防区域复发方面可能也有效,对于具有高危特征以及广泛淋巴结受累切除后的情况可考虑采用。